Press releases
- Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
- Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
- Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
- Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
- Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
More ▼
Key statistics
On Friday, Exelixis Inc (0IJO:LSE) closed at 21.64, -10.94% below its 52-week high of 24.30, set on Jan 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 21.64 |
Average volume | 391.40 |
---|---|
Shares outstanding | 291.29m |
Free float | 284.89m |
P/E (TTM) | 33.62 |
Market cap | 6.33bn USD |
EPS (TTM) | 0.6466 USD |
Data delayed at least 20 minutes, as of Jun 14 2024 15:19 BST.
More ▼